STAT

With Gottlieb’s resignation, the Trump administration loses its backroom whisperer on Capitol Hill

No one is better than Scott Gottlieb at selling the Trump administration’s health agenda on Capitol Hill. What happens when he's gone?
Source: J. Scott Applewhite/AP

WASHINGTON — The Trump administration just lost its most effective health policy salesman.

Scott Gottlieb, the charismatic FDA commissioner who announced this week he will step down in about a month, was better than any other administration official at selling key Trump administration policies — particularly those related to lowering prescription drug prices — on Capitol Hill, lawmakers and aides in both parties told STAT.

Gottlieb isn’t on television to of bringing down drug prices nearly as often as health secretary Alex Azar. Nor is his agency drafting many of the regulatory changes that have become the

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks